SinoMab BioScience Limited (3681.HK)
Develops antibody drugs to treat autoimmune and blood diseases in China.
1.27+0.04%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-59.3%
The outlook
SinoMab BioScience is trading near its 52-week low, sitting just 10% up from that floor. The stock shows mixed positioning against its moving averages, and analyst sentiment leans bearish overall. Today's minimal movement reflects the cautious tone around the stock.
What’s behind the score
Price trendMixed vs its moving averages
52-week range10% of the way from its 52-week low to high
Market cap
$1.76B
52-wk high
3.76
52-wk low
0.99
50-day avg
1.18
200-day avg
1.52
Trailing P/E
—